These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 3566256)
1. Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2'-nor-cyclic GMP on adenovirus replication in vitro. Baba M; Mori S; Shigeta S; De Clercq E Antimicrob Agents Chemother; 1987 Feb; 31(2):337-9. PubMed ID: 3566256 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2'-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro. Gordon YJ; Romanowski E; Araullo-Cruz T; Seaberg L; Erzurum S; Tolman R; De Clercq E Antiviral Res; 1991 Jul; 16(1):11-6. PubMed ID: 1776874 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against newly isolated clinical varicella-zoster virus strains. Baba M; Konno K; Shigeta S; De Clercq E Eur J Clin Microbiol; 1987 Apr; 6(2):158-60. PubMed ID: 3036498 [TBL] [Abstract][Full Text] [Related]
4. Comparative activity of various compounds against clinical strains of herpes simplex virus. Andrei G; Snoeck R; Goubau P; Desmyter J; De Clercq E Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):143-51. PubMed ID: 1327785 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication. Lin JC; De Clercq E; Pagano JS Antimicrob Agents Chemother; 1991 Nov; 35(11):2440-3. PubMed ID: 1666500 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of inhibition of adenovirus DNA replication by the acyclic nucleoside triphosphate analogue (S)-HPMPApp: influence of the adenovirus DNA binding protein. Mul YM; van Miltenburg RT; De Clercq E; van der Vliet PC Nucleic Acids Res; 1989 Nov; 17(22):8917-29. PubMed ID: 2587248 [TBL] [Abstract][Full Text] [Related]
7. Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method. Kodama E; Shigeta S; Suzuki T; De Clercq E Antiviral Res; 1996 Jul; 31(3):159-64. PubMed ID: 8811200 [TBL] [Abstract][Full Text] [Related]
8. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro. Hartline CB; Gustin KM; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER J Infect Dis; 2005 Feb; 191(3):396-9. PubMed ID: 15633099 [TBL] [Abstract][Full Text] [Related]
9. (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication. Snoeck R; Sakuma T; De Clercq E; Rosenberg I; Holy A Antimicrob Agents Chemother; 1988 Dec; 32(12):1839-44. PubMed ID: 2854454 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of African swine fever virus DNA synthesis by (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine. Arzuza O; García-Villalón D; Tabarés E; Gil-Fernández C; De Clercq E Biochem Biophys Res Commun; 1988 Jul; 154(1):27-32. PubMed ID: 3395330 [TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique. Snoeck R; Schols D; Andrei G; Neyts J; De Clercq E Antiviral Res; 1991 Jul; 16(1):1-9. PubMed ID: 1663725 [TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of broad-spectrum antiviral agents as inhibitors of African swine fever virus replication in vitro. Gil-Fernández C; De Clercq E Antiviral Res; 1987 Mar; 7(3):151-60. PubMed ID: 3475038 [TBL] [Abstract][Full Text] [Related]
14. [Sensitivities to other antiviral drugs and thymidine kinase activity of aciclovir-resistant herpes simplex virus type 1]. Nitta K; Shiota H; Naito T; Mimura Y Nippon Ganka Gakkai Zasshi; 1994 Jun; 98(6):513-9. PubMed ID: 8030564 [TBL] [Abstract][Full Text] [Related]
15. Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro. Shigeta S; Konno K; Baba M; Yokota T; De Clercq E J Infect Dis; 1991 Feb; 163(2):270-5. PubMed ID: 1846389 [TBL] [Abstract][Full Text] [Related]
16. Pretreatment of the host cell with 1-(S)-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) is sufficient for its antiviral effect. Otová B; Votruba I; Holý A Acta Virol; 1992 May; 36(3):313-9. PubMed ID: 1360759 [TBL] [Abstract][Full Text] [Related]
17. Antiretroviral activities of acyclic nucleoside phosphonates [9-(2-phosphonylmethoxyethyl)adenine, 9-(2-phosphonylmethoxyethyl)guanine, (R)-9-(2-phosphonylmethoxypropyl)adenine, and MDL 74,968] in cell cultures and murine sarcoma virus-infected newborn NMRI mice. Balzarini J; Vahlenkamp T; Egberink H; Hartmann K; Witvrouw M; Pannecouque C; Casara P; Navé JF; De Clercq E Antimicrob Agents Chemother; 1997 Mar; 41(3):611-6. PubMed ID: 9056002 [TBL] [Abstract][Full Text] [Related]
18. Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems. Balzarini J; Aquaro S; Perno CF; Witvrouw M; Holý A; De Clercq E Biochem Biophys Res Commun; 1996 Feb; 219(2):337-41. PubMed ID: 8604988 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue culture. Heijtink RA; Kruining J; de Wilde GA; Balzarini J; de Clercq E; Schalm SW Antimicrob Agents Chemother; 1994 Sep; 38(9):2180-2. PubMed ID: 7811041 [TBL] [Abstract][Full Text] [Related]
20. Phosphonylmethoxyalkyl derivatives of purine as inhibitors of human hepatitis B virus DNA synthesis. Yokota T; Mochizuki S; Konno K; Mori S; Shigeta S; De Clercq E Nucleic Acids Symp Ser; 1990; (22):17-8. PubMed ID: 2101900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]